Coronavirus Update: Ex-BARDA Chief: I Was Removed For Resisting Trump’s ‘Game Changer’ Drug
Furor Comes As Novartis Prepares Trial To Answer Data Doubts
Former BARDA leader says science not politics has to lead COVID-19 decision making. Plus Bayer launches Canada partnership, Korea pools research efforts.
You may also be interested in...
As potentially life-threatening heart problems emerge in coronavirus patients, FDA says hydroxychloroquine should be taken only in clinical trial or hospital settings under the Emergency Use Authorization.
Novartis/TScan and Gilead/Kite/oNKo-innate partnerships seek to advance cancer cell therapy. J&J, Bayer among the latest pharmas to unveil partnerships to fight the novel coronavirus.
Plus: Moleculin hopes to move 2-DG prodrug into clinic, India progresses niche COVID-19 defenses and more.